ClinicalTrials.Veeva

Menu

Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events

C

Cornell University

Status

Completed

Conditions

Cryptosporidiosis
Malnutrition
HIV

Study type

Observational

Funder types

Other

Identifiers

NCT01699841
IRB 1111002616

Details and patient eligibility

About

The purpose of this study is to understand how breast milk may protect infants from infection and promote favorable immunological, growth and development outcomes. By following mothers and their infants, we will evaluate the important interactions between infant immune responses and infectious disease events in relation to breast milk composition and feeding patterns. Our aim is to identify a set of predictive factors corresponding to healthy early infant growth and development in this setting in Northern Tanzania.

Enrollment

208 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Informed consent provided by mothers, and parental consent on behalf of their infants
  • Confirmed maternal HIV status (HIV-1, HIV-2 or HIV-Dual seropositive or HIV-seronegative)
  • Stated intention to remain in the clinic catchment area ≥6 months post-partum
  • Singleton birth

Exclusion criteria

  • None

Trial design

208 participants in 1 patient group

HIV+ and HIV- mothers and their infants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems